Abstract:The TrkB receptor, which is highly expressed in various human cancers and considered a pro-oncogene, was targeted to develop neutralizing monoclonal antibodies against its immunoglobulin-like (Ig-like) domains. Recombinant TrkB-IgL peptide, including the Ig-like C2 type 1 (Ig-C2-type 1) and Ig-like C2 type 2 (Ig-C2-type 2) domains, was expressed and purified from E. coli. Mice were immunized with this peptide, and hybridoma clones producing anti-TrkB-IgL antibodies were generated. Among 23 ELISA-positive TrkB-IgL hybridoma clones, four (TrkB-IgL 5.11, 4.11, 4.6, 4.3) showed anti-proliferative effects compared to the control on human breast cancer (MCF-7) and human colon cancer (HCT116) cells, as assessed using the xCELLigence system. Western blot analysis revealed that TrkB-IgL 5.11 and 4.11 significantly suppressed TrkB-mediated signaling pathways compared to the control. Purified TrkB-IgL monoclonal antibodies (mAbs) exhibited anti-proliferative effects compared to both positive and negative controls using the xCELLigence system. The TrkB-IgL 5.11 mAb notably suppressed phosphorylation of TrkB, Akt, and ERK and induced Caspase-3 and Caspase-9 activities in a dose-dependent manner, as determined by Western blotting. Additionally, immunostaining confirmed the localization of these mAbs on the SH-SY5Y cell membrane, which is known for high TrkB expression. In conclusion, the TrkB-IgL 5.11 antibody effectively inhibits cancer cell proliferation and induces apoptosis by suppressing key signaling pathways. These findings demonstrate the potential of this antibody as a therapeutic agent for cancers that overexpress TrkB. Additionally, it is considered a promising candidate for humanization, which would facilitate its application in cancer treatment. Supplementary information: The online version contains supplementary material available at 10.1007/s13205-024-04063-x.

The Production and Application of TRIP-1 Antibody

Preparation and Identification of Monoclonal Antibody Against Human Testis Development Related Gene 1

[Preparation and Characterization of Monoclonal Antibody Against Human Telomeric Repeat Binding Factor 1].

Production and Characterization of a Monoclonal Antibody Against GRAM Domain-Containing Protein 1A

Generation and Characterisation of Rabbit Monoclonal Antibodies Against the Native Cell Surface Antigens of Embryonic Stem Cells.

Production of rabbit monoclonal antibodies against mouse embryonic stem cells and identification of pluripotency-associated surface antigens.

Preparation and Identification of Polyclonal Antibodies Against LPTS

Preparation and Identification of the Rabbit Anti-human Immune-related Gene Guanosine Triphosphate Polyclonal Antibody

The Preparation and Preliminary Application of the Epitope Peptide-Based Antibody Against TRIM22

Prokaryotic expression and polyclonal antibody preparation of human novel gene CTRP4]

A Novel Human Fab Antibody for Trop2 Inhibits Breast Cancer Growth in Vitro and in Vivo

Expression and Preparation of Antiserum of Human KCTD10 and Its Expression Profile in the Cell Lines

Preparation and Identification of Rabbit Anti-human Pre-mRNA Splicing Protein Tra2β1 Antibody

Preparation and Characterization of Monoclonal Antibody Against Human Angiopoietin-Like Protein 2

Expression of a Recombinant Anti-Programed Cell Death 1 Antibody in the Mammary Gland of Transgenic Mice

Development of a rabbit monoclonal antibody group against Smads and immunocytochemical study of human and mouse embryonic stem cells.

The Production and Application of Ezrin Polyclonal Antibody

Preparation of anti-recombinant soluble tissue factor monoclonal antibody by trace injecting antigen into spleen

Preparation and Analysis of Polycolonal Antibody Against ANGPTL 2 Fibrinogen Like Domain

Developing a novel neutralizing monoclonal antibody against TrkB

Preparation and characterization of monoclonal antibody against hTSC29 pep-tides